AIM
AIM ImmunoTech Inc. (AIM) ESG Analysis Analysis (2026)
No material changes this month.
Environmental
R&D intensity at 28.9% of revenue suggests a comparatively resource-efficient operating model versus heavier industrial peers, though sector-specific emissions data are not provided.
Low leverage with debt-to-equity of 0.51 and net debt-to-EBITDA of 0.46 can support environmental investment flexibility versus more indebted peers.
Negative gross margin indicates limited operating headroom, which can constrain funding for decarbonization initiatives relative to better-margin peers.
No direct emissions, energy, water, or waste disclosures were provided, limiting evidence of environmental leadership versus peers.
Social
Zero stock-based compensation to revenue suggests lower dilution pressure and potentially less employee-alignment complexity than peers that rely more heavily on equity pay.
High R&D spending can support workforce skill development and product safety oversight, but the provided data do not confirm broader labor or community outcomes.
No workforce, safety, turnover, diversity, or customer-responsibility metrics were provided, so social positioning versus peers remains only partially evidenced.
Negative gross margin may constrain investment in employee programs and stakeholder initiatives relative to peers with stronger operating buffers.
Governance
Zero stock-based compensation indicates restrained equity dilution and a cleaner incentive structure than peers with heavier share-based compensation use.
Moderate leverage suggests balance-sheet discipline and lower creditor pressure than more levered peers, supporting governance resilience.
High R&D intensity can reflect disciplined capital allocation when paired with low leverage, though the absence of board and control disclosures limits confirmation.
No evidence of major controversies or governance failures was provided, which supports a stronger relative governance profile versus peers.
Overall Score
AIM appears moderately positioned versus peers, with governance and balance-sheet discipline offset by limited disclosed environmental and social evidence.
Score Driver: Governance Strength From Low Leverage And Zero Stock-Based Compensation
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on AIM ImmunoTech Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
